Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global artificial pancreas device systems market 360° synopsis, 2018 – 2032
2.2 Regional trends
2.3 Device type trends
2.4 End-use trends
Chapter 3 Artificial Pancreas Device Systems Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Growing prevalence of diabetes
3.5.1.2 Rising demand for automated systems for glycemic control
3.5.1.3 Technological advancements in continuous glucose monitoring sensors
3.5.1.4 Increasing research and development activities by key players
3.5.2 Industry pitfalls & challenges
3.5.2.1 High cost of device systems and safety concerns
3.5.2.2 Stringent regulatory framework
3.6 Growth potential analysis
3.6.1 By device type
3.6.2 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Competitive analysis of major market players, 2022
4.2.1 Medtronic Plc
4.2.2 Johnson & Johnson Services Inc
4.2.3 Tandem Diabetes Care, Inc.
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Artificial Pancreas Device Systems Market Size and Forecast, By Device Type, 2018-2032 (USD Million & Units)
5.1 Key trends, by device type
5.2 Threshold suspend device systems
5.3 Control-to-range (CTR) systems
5.4 Control-to-target (CTT) systems
Chapter 6 Artificial Pancreas Device Systems Market Size and Forecast, By End-use, 2018-2032 (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals and clinics
6.3 Homecare
6.4 Others
Chapter 7 Artificial Pancreas Device Systems Market Size and Forecast, By Region, 2018-2032 (USD Million & Units)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pcific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Rest of Middle East & Africa
Chapter 8 Company Profiles
8.1 Medtronic Plc
8.2 Johnson & Johnson Services Inc
8.3 Bigfoot Biomedical
8.4 Tandem Diabetes Care, Inc.
8.5 Pancreum, Inc.
8.6 TypeZero Technologies, LLC
8.7 Beta Bionics
8.8 Insulet Corporation
8.9 Defymed
8.10 Inreda Diabetic
8.11 Diabeloop
